Hydreight Technologies Inc. has announced a strategic partnership with Perfect Scripts LLC, a Texas-based company. Under the binding letter of intent, Hydreight will acquire an initial 5% equity stake in Perfect Scripts, with an option to increase this to 40%. The partnership aims to establish a 503B pharmacy in the United States, ensuring Hydreight access to the lowest pricing for products from Perfect Scripts. This collaboration is expected to enhance Hydreight's control over pharmaceutical production, distribution, and pricing, particularly for key medications, and strengthen its position in the U.S. healthcare market. The partnership is anticipated to provide increased margins, a secure supply chain, and greater vertical integration for Hydreight, supporting its mission to improve access to modern healthcare.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。